Barclays
STML

Barclays’s Stemline Therapeutics, Inc. STML Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-16,745
Closed -$81K 4089
2020
Q1
$81K Sell
16,745
-30,946
-65% -$150K ﹤0.01% 2916
2019
Q4
$507K Buy
47,691
+23,905
+101% +$254K ﹤0.01% 2677
2019
Q3
$248K Sell
23,786
-2,153
-8% -$22.4K ﹤0.01% 2967
2019
Q2
$398K Buy
25,939
+13,859
+115% +$213K ﹤0.01% 2851
2019
Q1
$155K Sell
12,080
-28,013
-70% -$359K ﹤0.01% 3141
2018
Q4
$381K Buy
40,093
+24,497
+157% +$233K ﹤0.01% 2412
2018
Q3
$258K Sell
15,596
-2,266
-13% -$37.5K ﹤0.01% 2944
2018
Q2
$286K Sell
17,862
-5,561
-24% -$89K ﹤0.01% 2566
2018
Q1
$358K Buy
23,423
+10,254
+78% +$157K ﹤0.01% 2504
2017
Q4
$206K Sell
13,169
-5,241
-28% -$82K ﹤0.01% 2637
2017
Q3
$204K Buy
18,410
+16,793
+1,039% +$186K ﹤0.01% 2383
2017
Q2
$15K Sell
1,617
-975
-38% -$9.05K ﹤0.01% 3355
2017
Q1
$22K Buy
2,592
+957
+59% +$8.12K ﹤0.01% 3351
2016
Q4
$18K Buy
1,635
+142
+10% +$1.56K ﹤0.01% 3131
2016
Q3
$16K Buy
1,493
+106
+8% +$1.14K ﹤0.01% 3116
2016
Q2
$9K Buy
+1,387
New +$9K ﹤0.01% 3024
2015
Q4
Sell
-82
Closed -$1K 3966
2015
Q3
$1K Sell
82
-217
-73% -$2.65K ﹤0.01% 3834
2015
Q2
$3K Sell
299
-152
-34% -$1.53K ﹤0.01% 3844
2015
Q1
$7K Sell
451
-487
-52% -$7.56K ﹤0.01% 3586
2014
Q4
$16K Sell
938
-1,998
-68% -$34.1K ﹤0.01% 3525
2014
Q3
$35K Buy
2,936
+2,740
+1,398% +$32.7K ﹤0.01% 3166
2014
Q2
$3K Sell
196
-2,570
-93% -$39.3K ﹤0.01% 4067
2014
Q1
$55K Sell
2,766
-7,080
-72% -$141K ﹤0.01% 3100
2013
Q4
$187K Buy
9,846
+9,504
+2,779% +$181K ﹤0.01% 2679
2013
Q3
$15K Sell
342
-139
-29% -$6.1K ﹤0.01% 3572
2013
Q2
$11K Buy
+481
New +$11K ﹤0.01% 3877